Pharmacokinetics of doxycycline in sheep after intravenous and oral administration

The pharmacokinetics of doxycycline were investigated in sheep after oral (PO) and intravenous (IV) administration. The IV data were best described using a 2- (n = 5) or 3- (n = 6) compartmental open model. Mean pharmacokinetic parameters obtained using a 2-compartmental model included a volume of distribution at steady-state (V_ss) of 1.759 ± 0.3149 L/kg, a total clearance (Cl) of 3.045 ± 0.5264 mL/kg/min and an elimination half-life (t_1/2β) of 7.027 ± 1.128 h. Comparative values obtained from the 3-compartmental mean values were: V_ss of 1.801 ± 0.3429 L/kg, a Cl of 2.634 ± 0.6376 mL/kg/min and a t_1/2β of 12.11 ± 2.060 h. Mean residence time (MRT_0−∞) was 11.18 ± 3.152 h. After PO administration, the data were best described by a 2-compartment open model. The pharmacokinetic parameter mean values were: maximum plasma concentration (C_max), 2.130 ± 0.950 μg/mL; time to reach C_max (t_max), 3.595 ± 3.348 h, and absorption half-life (t_1/2k01), 36.28 ± 14.57 h. Non-compartmental parameter values were: C_max, 2.182 ± 0.9117 μg/mL; t_max, 3.432 ± 3.307 h; F, 35.77 ± 10.20%, and mean absorption time (MAT_0–∞), 25.55 ± 15.27 h. These results suggest that PO administration of doxycycline could be useful as an antimicrobial drug in sheep.     

Expression of HIF-1α in rat's radiation-induced oral mucositis

AIM: To detect the mRNA and protein level of HIF-1 alpha in the tissues of rat's radiated mucosa. METHODS: The left buccal mucosa was irradiated and excised. The right buccal mucosa was excised to serve as own control tissue. The mRNA of HIF-1 alpha was determined by using the semi quantitative RT-PCR. SABC method was employed to immunostain and to elucidate the localization, intensity and distribution of HIF-1 alpha protein.RESULTS: A Sprague-Dawley rat's model of radiation-induced oral mucositis (ROM) was successfully established. The results of RT-PCR indicated that the left buccal mucosa expressed HIF-1 alpha mRNA while the right buccal mucosa did not or seldom expressed it. Immunohistochemical analysis of HIF-1 alpha demonstrated that the left side mucosa expressed HIF-1 alpha protein.CONCLUSION: The mucosa of ROM expresses the mRNA and protein of HIF-1 alpha. The expressions of HIF-1 alpha are correlated with the severity of ROM.     

双葛止泻口服液微生物限度检查方法学验证

建立了双葛止泻口服液的微生物限度检查方法.根据2015年版《中华人民共和国兽药典(二部)》通则1102非无菌产品微生物限度检查:微生物计数法,以及通则1103非无菌产品微生物限度检查:控制菌检查法和通则1104非无菌兽药微生物限度标准进行方法适用性试验.结果 表明,采用薄膜过滤法对样品进行需氧菌总数、霉菌和酵母菌计数方...     

捕食线虫性真菌—少孢节丛孢菌口服生物制剂安全性试验

为研究少孢节丛孢菌口服生物制剂的安全性,将20只6月龄绵羊分成4组,前3组分别灌服含有1.0×105、1.0×106、1.0×107少孢节丛孢菌分生孢子口服生物制剂,第4组为对照组灌服灭菌的生理盐水,灌服后连续30d观察绵羊的各项临床指标;并在7d后每组分别剖检2只绵羊,无菌采集绵羊各器官组织,进行组织切片和少孢节丛孢菌的分离鉴定;另外,将12只感染捻转血矛线虫后的绵羊分成3组,灌服3个不同剂量的生物制剂后测定其对粪便中线虫的捕食活性。结果表明,绵羊的精神状态、食欲、饮水、体温、粪便、增量正常;绵羊肝脏、脾脏、肾脏、肠道淋巴结等组织器官没有出现病理变化;也未从上述组织中分离出少孢节丛孢菌;3个不同剂量的生物制剂均可显著降低绵羊粪便中的幼虫数量。研究结果证实,少孢节丛孢菌口服生物制剂安全有效,无毒副作用。